{"id":995145,"date":"2026-08-13T16:29:45","date_gmt":"2026-08-13T20:29:45","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/mangoceuticals-inc-s-merger-partner-nuclea-energy-inc-enters-into-definitive-agreement-to-acquire-moltex-energys-advanced-nuclear-technology-assets\/"},"modified":"2026-08-13T16:29:45","modified_gmt":"2026-08-13T20:29:45","slug":"mangoceuticals-inc-s-merger-partner-nuclea-energy-inc-enters-into-definitive-agreement-to-acquire-moltex-energys-advanced-nuclear-technology-assets","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/mangoceuticals-inc-s-merger-partner-nuclea-energy-inc-enters-into-definitive-agreement-to-acquire-moltex-energys-advanced-nuclear-technology-assets\/","title":{"rendered":"Mangoceuticals Inc.\u2019s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy\u2019s Advanced Nuclear Technology Assets"},"content":{"rendered":"
\n

\n The acquisition of Moltex brings over a decade of advanced nuclear R&D, backed by more than C$96 million in private investment and public funding from Canada and the U.S. Department of Energy.<\/i>\n <\/p>\n

\n Asset-led transaction to add intellectual property and development materials related principally to the SSR-W advanced reactor and WATSS spent nuclear fuel recycling technologies.<\/i>\n <\/p>\n

\n DALLAS, Texas, Aug. 13, 2026 (GLOBE NEWSWIRE) — <\/strong>Mangoceuticals, Inc. (NASDAQ: MGRX) (\u201cMangoceuticals\u201d or the \u201cCompany\u201d) today announced that its merger partner, Nuclea Energy, Inc. (\u201cNuclea\u201d), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing the Morpheus microreactor, a lead-cooled, factory-built micro-modular reactor, through its wholly owned subsidiary, Nuclea Energy Canada Inc. (\u201cNuclea Canada\u201d), has entered into a definitive agreement with Moltex Energy Limited (\u201cMoltex\u201d) \u2013 currently in administration \u2013 and its joint administrators to acquire advanced nuclear technology assets across its molten salt reactor and nuclear fuel recycling portfolio.<\/p>\n

The target portfolio has been developed over more than a decade, backed by over C$96 million in funding from private investment, Canadian public programs, and the U.S. Department of Energy. Contributors include the Province of New Brunswick, the Government of Canada\u2019s Strategic Innovation Fund, the Atlantic Canada Opportunities Agency, and the U.S. Department of Energy through ARPA-E programs. Moltex\u2019s SSR-W reactor completed Phase 1 of the Canadian Nuclear Safety Commission’s Vendor Design Review program, and WATSS advanced under a Service Level Agreement with the Canadian Nuclear Safety Commission. The technologies were developed in collaboration with partners including Ontario Power Generation, CANDU Energy Inc. (now part of AtkinsR\u00e9alis), Argonne National Laboratory, Oak Ridge National Laboratory and the Electric Power Research Institute.<\/p>\n

The transaction is structured principally as an acquisition of assets. The target portfolio is expected to include technology and development materials associated principally with Moltex’s Stable Salt Reactor\u2013Wasteburner (SSR-W), an advanced molten salt fast reactor, and its next-generation Waste To Stable Salt (WATSS) spent nuclear fuel recycling process, together with an extensive patent portfolio of 80 patents across 9 patent families in advanced nuclear technology \u2013 including nuclear fuel, reactor, chemistry and materials \u2013 as well as 9 pending patents on the fuel recycling process.<\/p>\n

\u201cWe believe the nuclear sector is entering a sustained period of strategic investment driven by the increasing competition in nuclear developments between east and west, energy security, grid reliability, industrial electrification and growing demand for large volumes of dependable, low-carbon power driven by the new digital age,\u201d said Josef Freundorfer, Nuclea\u2019s Chief Executive Officer. \u201cThis agreement is designed to broaden Nuclea\u2019s position within the nuclear sector by adding a pair of advanced reactor designs and nuclear fuel-cycle technology that are complementary to our Morpheus microreactor. Importantly, this is an asset-led transaction at what we believe is a disciplined entry point, with future capital deployment governed by clearly defined technical, regulatory and commercial milestones.\u201d<\/p>\n

Under the agreement, Nuclea Energy Canada will satisfy the purchase price entirely in cash, exclusive of any applicable value-added tax and subject to a downward adjustment for certain defined external debts.<\/p>\n

\n Expanding Nuclea\u2019s Advanced Nuclear Technology Platform<\/b>\n <\/p>\n

Nuclea\u2019s Morpheus microreactor is being designed as a compact, transportable and factory-fabricated microreactor platform for applications requiring secure and reliable power, including data centers, industrial facilities, defense infrastructure, mining operations, and remote communities.<\/p>\n

The proposed Moltex asset acquisition would extend Nuclea\u2019s technology portfolio into advanced modular and potentially grid-scale nuclear generation, as well as spent-fuel recycling. These include:<\/p>\n